Your browser doesn't support javascript.
loading
Relationship between motor cortical and peripheral axonal hyperexcitability in amyotrophic lateral sclerosis.
Suzuki, Yo-Ichi; Shibuya, Kazumoto; Misawa, Sonoko; Suichi, Tomoki; Tsuneyama, Atsuko; Kojima, Yuta; Nakamura, Keigo; Kano, Hiroki; Prado, Mario; Aotsuka, Yuya; Otani, Ryo; Morooka, Marie; Kuwabara, Satoshi.
Afiliação
  • Suzuki YI; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Shibuya K; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan kazumoto@net.email.ne.jp.
  • Misawa S; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Suichi T; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Tsuneyama A; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Kojima Y; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Nakamura K; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Kano H; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Prado M; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Aotsuka Y; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Otani R; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Morooka M; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
  • Kuwabara S; Neurology, Chiba University, Graduate School of Medicine, Chiba, Japan.
Article em En | MEDLINE | ID: mdl-35995552
BACKGROUND: Previous studies have shown that patients with amyotrophic lateral sclerosis (ALS) have hyperexcitability in both the motor cortex and peripheral motor axons, but the relationship between central and peripheral excitability has not been fully disclosed. METHODS: Threshold tracking transcranial magnetic stimulation (TMS) and motor nerve excitability testing were prospectively performed in 53 patients with ALS and 50 healthy subjects, and their relations to compound muscle action potential (CMAP) amplitude and revised ALS Functional Rating Scale were cross-sectionally analysed. RESULTS: Compared with controls, patients with ALS showed both cortical and peripheral hyperexcitability; TMS showed reduced short-interval intracortical inhibition (interstimulus interval 1-7 ms) (p<0.001) and shortened silent period (p<0.05), and median nerve excitability testing revealed greater changes in depolarising threshold electrotonus (TEd) and greater superexcitability (p<0.0001, both), suggesting reduced axonal potassium currents. Significant correlations between cortical and peripheral excitability indices were not found. Greater changes in TEd (90-100 ms) (R=-0.33, p=0.03) and superexcitability (R=0.36, p=0.01) were associated with smaller amplitude of CMAP, whereas cortical excitability indices had no correlation with CMAP amplitude. More rapid motor functional decline was associated with only greater TEd (90-100 ms) (ß=0.46, p=0.001). CONCLUSIONS: Our results suggest that in ALS, cortical excitability is continuously high regardless of the extent of the peripheral burden, but peripheral hyperexcitability is associated with the extent of the peripheral burden and disease evolution speed. Alterations of ion channel function may play an important role in ALS pathophysiology.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article